diltiazem has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berk-Krauss, J; Christman, MP; Franks, A; Liebman, TN; Sicco, KL | 1 |
| Kutty, KK; Ledge, GS; Mahesh, A; Rajendran, CP; Ramesh, S | 1 |
2 other study(ies) available for diltiazem and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
| Article | Year |
|---|---|
Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome.
Topics: Acetylcholine Release Inhibitors; Administration, Topical; Aged; Botulinum Toxins; CREST Syndrome; Diltiazem; Female; Humans; Nitroglycerin; Pain; Raynaud Disease; Sildenafil Citrate; Treatment Failure; Ulcer; Vasodilator Agents | 2018 |
Childhood systemic sclerosis with calcified foci over scalp.
Topics: Adolescent; Calcinosis; CREST Syndrome; Diltiazem; Humans; Male; Scalp Dermatoses | 2004 |